BioMarin Pharmaceutical
BMRN
#1907
Rank
S$13.29 B
Marketcap
S$69.20
Share price
-0.78%
Change (1 day)
-21.86%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.78 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total debt is S$0.78 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioMarin Pharmaceutical - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$0.81 B-43.39%
2023-12-31S$1.44 B-1.27%
2022-12-31S$1.46 B-0.49%
2021-12-31S$1.47 B2.44%
2020-12-31S$1.43 B24.19%
2019-12-31S$1.15 B2.06%
2018-12-31S$1.13 B-27.78%
2017-12-31S$1.57 B58.86%
2016-12-31S$0.98 B5.55%
2015-12-31S$0.93 B10.28%
2014-12-31S$0.84 B2.28%
2013-12-31S$0.83 B95.05%
2012-12-31S$0.42 B-5.6%
2011-12-31S$0.45 B-7.24%
2010-12-31S$0.48 B-30.32%
2009-12-31S$0.69 B-14.06%
2008-12-31S$0.81 B13.46%
2007-12-31S$0.71 B102.3%
2006-12-31S$0.35 B-5.25%
2005-12-31S$0.37 B-15.49%
2004-12-31S$0.44 B108.05%
2003-12-31S$0.21 B
2001-12-31S$10.27 M7044.77%
2000-12-31S$0.14 M-22.16%
1999-12-31S$0.18 M11.94%
1998-12-31S$0.16 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$43.84 M-94.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$32.94 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.39 B-49.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$33.08 B 4,125.35%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
S$0.57 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$3.74 M-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA